We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

468 hedge funds and large institutions have $3.48B invested in iShares US Medical Devices ETF in 2020 Q2 according to their latest regulatory filings, with 138 funds opening new positions, 194 increasing their positions, 75 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

345% more first-time investments, than exits

New positions opened: 138 | Existing positions closed: 31

159% more repeat investments, than reductions

Existing positions increased: 194 | Existing positions reduced: 75

98% more capital invested

Capital invested by funds: $1.76B → $3.48B (+$1.72B)

57.85% more ownership

Funds ownership: 253.69%311.54% (+58%)

35% more funds holding in top 10

Funds holding in top 10: 1723 (+6)

29% more funds holding

Funds holding: 364468 (+104)

84% less call options, than puts

Call options by funds: $10.8M | Put options by funds: $69.5M

Holders
468
Holders Change
+104
Holders Change %
+28.57%
% of All Funds
9.6%
Holding in Top 10
23
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+35.29%
% of All Funds
0.47%
New
138
Increased
194
Reduced
75
Closed
31
Calls
$10.8M
Puts
$69.5M
Net Calls
-$58.7M
Net Calls Change
-$50.3M
Name Holding Trade Value Shares
Change
Change in
Stake
CAM
151
Concorde Asset Management
Michigan
$2.18M +$1.51M +35,304 +252%
MAFM
152
Mid Atlantic Financial Management
Pennsylvania
$2.17M +$699K +16,356 +50%
TSA
153
Tri-Star Advisors
Texas
$2.15M +$1.93M +45,168 New
I
154
INVST
Indiana
$2.15M +$2.07M +48,468 New
RFWA
155
RPg Family Wealth Advisory
Massachusetts
$2.14M +$1.89M +44,184 +1,001%
SSWM
156
Sheets Smith Wealth Management
North Carolina
$2.14M +$2.07M +48,474 New
SFS
157
Sowell Financial Services
Arkansas
$2.13M +$1.01M +23,640 +96%
SB
158
Strategic Blueprint
Georgia
$2.13M +$2.06M +48,168 New
OCM
159
Orleans Capital Management
Louisiana
$2.09M +$2.03M +47,430 New
SXL
160
Summit X LLC
Missouri
$2.09M +$2.03M +47,430 New
NFG
161
Next Financial Group
Texas
$2.07M +$929K +21,744 +86%
HW
162
Hamilton Wealth
California
$2.06M +$146K +3,408 +8%
SFA
163
Sequoia Financial Advisors
Ohio
$2.05M +$215K +5,022 +12%
DWM
164
Destination Wealth Management
California
$2.04M +$69.7K +1,632 +4%
FLAM
165
First Light Asset Management
Minnesota
$2.01M
CAM
166
Cypress Asset Management
Texas
$1.97M +$80.8K +1,890 +4%
DC
167
Davenport & Co
Virginia
$1.96M -$583K -13,638 -23%
OC
168
Oppenheimer & Co
New York
$1.95M -$247K -5,784 -12%
CWM
169
Cornerstone Wealth Management
Missouri
$1.92M +$637K +14,898 +52%
CF
170
Centaurus Financial
California
$1.9M +$96.7K +2,262 +6%
CWM
171
Concentrum Wealth Management
California
$1.87M +$1.81M +42,318 New
FCA
172
FLC Capital Advisors
California
$1.83M +$1.73M +40,470 New
VFA
173
Voya Financial Advisors
Connecticut
$1.83M +$200K +4,680 +12%
WS
174
Wedbush Securities
California
$1.82M +$25.4K +594 +1%
AAS
175
Avantax Advisory Services
Texas
$1.82M +$448K +10,482 +34%

IHI Hedge Fund Activity: Q2 2020 in Review

468 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q2 2020, worth a combined $3.48B — up 98% from $1.76B a quarter earlier.

Buyers outnumbered sellers: 138 funds opened new IHI positions and 31 closed out — a net gain of 107 holders — while 194 added to existing stakes and 75 trimmed.

The largest buyer was Envestnet Asset Management, adding an estimated $412M. The largest seller was Goldman Sachs, cutting an estimated $83M.

  • 468 institutional investors held iShares US Medical Devices ETF (IHI) as of Q2 2020, up from 364 in Q1 2020.
  • Funds reported $3.48B of iShares US Medical Devices ETF stock for Q2 2020, up 98% quarter-over-quarter.
  • 138 funds opened new iShares US Medical Devices ETF positions in Q2 2020 and 31 closed out, a net change of +107 holders.
  • The largest iShares US Medical Devices ETF buyer in Q2 2020 was Envestnet Asset Management, an estimated $412M added.
  • The largest iShares US Medical Devices ETF seller in Q2 2020 was Goldman Sachs, an estimated $83M sold.

Based on aggregated 13F filings for Q2 2020.